Acanthamoeba keratitis.
Ho
Thomas C K
TC
D015823:Acanthamoeba Keratitis / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D002425:Cautery; D002710:Chlorhexidine / Q000008:administration & dosage / Q000627:therapeutic use; D003646:Debridement; D004338:Drug Combinations; D006801:Humans; D008795:Metronidazole / Q000008:administration & dosage / Q000627:therapeutic use; D009355:Neomycin / Q000008:administration & dosage / Q000627:therapeutic use; D009883:Ophthalmic Solutions; D012307:Risk Factors
D000891:Anti-Infective Agents, Local; D000981:Antiprotozoal Agents; D004338:Drug Combinations; D009883:Ophthalmic Solutions; D008795:Metronidazole; D009355:Neomycin; D002710:Chlorhexidine